Alexion Pharmaceuticals, Inc.
Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders

Abstract:

The disclosure relates to methods for detecting PNH Type II cell populations in biological samples as well as methods for determining whether a patient is at an increased risk for developing thrombocytopenia or thrombosis based on the percentage of PNH Type II cells in the patient's blood. The disclosure also features reagents and conjugates for use in the methods.